These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30801786)

  • 41. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract]   [Full Text] [Related]  

  • 42. Generalized pustular psoriasis treated with ustekinumab.
    Storan ER; O'Gorman SM; Markham T
    Clin Exp Dermatol; 2016 Aug; 41(6):689-90. PubMed ID: 27333948
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG
    Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497
    [No Abstract]   [Full Text] [Related]  

  • 44. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 46. Psoriasis: state of the art 2013.
    de la Brassinne M; Nikkels A
    Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acitretin].
    Dubertret L
    Ann Dermatol Venereol; 2011 Dec; 138(12):829-32. PubMed ID: 22137620
    [No Abstract]   [Full Text] [Related]  

  • 48. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
    Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
    JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
    Nikolaou V; Sibaud V; Fattore D; Sollena P; Ortiz-Brugués A; Giacchero D; Romano MC; Riganti J; Lallas K; Peris K; Voudouri D; Lallas A; Fabbrocini G; Lazaridou E; Carrera C; Annunziata MC; Rossi E; Patri A; Rigopoulos D; Stratigos AJ; Apalla Z
    J Am Acad Dermatol; 2021 May; 84(5):1310-1320. PubMed ID: 33279646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long-term control of psoriasis is necessary].
    Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining traditional agents and biologics for the treatment of psoriasis.
    Cather JC; Menter A
    Semin Cutan Med Surg; 2005 Mar; 24(1):37-45. PubMed ID: 15900797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.
    Carpentieri A; Pacello L; De Marco IM; Loiacono A; Picconi O; Loconsole F
    J Dermatolog Treat; 2016 Oct; 27(5):399-405. PubMed ID: 26822691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
    Rim JH; Park JY; Choe YB; Youn JI
    Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small Molecules for Psoriasis.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S65-6. PubMed ID: 27525564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Systemic retinoids (acitretin, isotretinoin)].
    Berbis P
    Ann Dermatol Venereol; 2007 Dec; 134(12):935-41. PubMed ID: 18166914
    [No Abstract]   [Full Text] [Related]  

  • 59. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme.
    Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM
    Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on psoriasis therapy: a perspective from the USA.
    Koo J; Liao W
    Keio J Med; 2000 Mar; 49(1):20-5. PubMed ID: 10750377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.